The US Environmental Protection Agency is accelerating its shift away from testing certain chemicals on animals as it reinstitutes a 2035 deadline that President Joe Biden’s administration scrapped in ...

Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with living “organ sacks” grown from human cells. R3 Bio, a billionaire-backed biotech startup, is ...

Xylazine, a veterinary sedative, is now a growing global drug threat. Often mixed with opioids like fentanyl, it increases overdose risk and causes severe health damage, including skin ulcers and limb ...

A biotech startup seeks to end animal testing with the creation of headless human bodyoids. Sad sack or serious salvation? A small group of scientists is angling to replace laboratory animals with ...

The scientific wonderers at What If weigh the progress of medical research against the moral shift of using only digital simulations and lab-grown tissues. Bondi accused of accidentally revealing ...

Add Yahoo as a preferred source to see more of our stories on Google. March 25 (Reuters) - Britain's medicines regulator said on Wednesday it will introduce a framework by the end of 2026, ‌which ...

Britain's medicines regulator said on Wednesday it will introduce a framework by the end of ​2026, which would allow drugmakers to ask a review of the ‌data for drugs being developed without animal ...

Animal testing for new drugs is being phased out because of advances made in artificial intelligence (AI), the UK’s medicines regulator has said. In an announcement on Tuesday, the Medicines and ...

As the Trump administration phases out the use of animal experimentation across the federal government, a biotech startup has a bold idea for an alternative to animal testing: nonsentient “organ sacks ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.